ChemicalBook > CAS DataBase List > Dotinurad

Dotinurad

Product Name
Dotinurad
CAS No.
1285572-51-1
Chemical Name
Dotinurad
Synonyms
Dotinurad;Dotinurad (FYU-981);3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole;(3,5-Dichloro-4-hydroxyphenyl)(1,1-dioxido-3(2H)-benzothiazolyl)methanone;(3,5-dichloro-4-hydroxyphenyl)(1,1-dioxidobenzo[d]thiazol-3(2H)-yl)methanone;Methanone, (3,5-dichloro-4-hydroxyphenyl)(1,1-dioxido-3(2H)-benzothiazolyl)-;uricosuric,Inhibitor,Dotinurad,URAT1,urate,reabsorption,SLC22A12,Urate transporter 1,inhibit,transporter
CBNumber
CB44667832
Molecular Formula
C14H9Cl2NO4S
Formula Weight
358.2
MOL File
1285572-51-1.mol
More
Less

Dotinurad Property

Melting point:
188 - 191°C
Boiling point:
614.8±55.0 °C(Predicted)
Density 
1.662±0.06 g/cm3(Predicted)
storage temp. 
-20°C Freezer, Under inert atmosphere
solubility 
Chloroform (Slightly, Sonicated), DMSO (Sparingly)
pka
4.60±0.25(Predicted)
form 
Solid
color 
White to Off-White
InChI
InChI=1S/C14H9Cl2NO4S/c15-9-5-8(6-10(16)13(9)18)14(19)17-7-22(20,21)12-4-2-1-3-11(12)17/h1-6,18H,7H2
InChIKey
VOFLAIHEELWYGO-UHFFFAOYSA-N
SMILES
C(C1=CC(Cl)=C(O)C(Cl)=C1)(N1C2=CC=CC=C2S(=O)(=O)C1)=O
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-0030545
Product name
Dotinurad
Purity
98.10%
Packaging
5mg
Price
$350
Updated
2021/12/16
ChemScene
Product number
CS-0030545
Product name
Dotinurad
Purity
98.10%
Packaging
10mg
Price
$550
Updated
2021/12/16
ChemScene
Product number
CS-0030545
Product name
Dotinurad
Purity
98.10%
Packaging
25mg
Price
$990
Updated
2021/12/16
ChemScene
Product number
CS-0030545
Product name
Dotinurad
Purity
98.10%
Packaging
50mg
Price
$1650
Updated
2021/12/16
ChemScene
Product number
CS-0030545
Product name
Dotinurad
Purity
98.10%
Packaging
100mg
Price
$2250
Updated
2021/12/16
More
Less

Dotinurad Chemical Properties,Usage,Production

Description

Dotinurad is an organic compound with the chemical Name (3,5-dichloro-4-hydroxyphenyl)(1,1-dioxidobenzo[d]thiazol-3(2H)-yl)methanone. This compound is a newer urate-lowering agent that suppresses uric acid reabsorption through the selective inhibition of urate transporter 1 (URAT1) in the proximal renal tubules, and it was first approved in Japan in 2020 for the treatment of hyperuricemia, irrespective of gout[1].

Uses

Dotinurad is a useful drug for treating hyperuricemia and gout.

Pharmacokinetics

The plasma concentration of dotinurad increased in a dose-dependent manner with Cmax and AUC0–24h values of 107 μg/ml and 780 μg.h/ml, respectively, at a dose of 30 mg/kg. Dotinurad dose-dependently lowered the plasma urate levels with its maximum effect at 8 h. Changes in plasma urate level between 0 and 8 h (ΔPUA) were lower than that of control by 0.28, 0.97 (p < 0.05), and 1.79 mg/dl (p < 0.01), at doses of 1, 5, and 30 mg/kg, respectively. Furthermore, dotinurad dose-dependently increased FEUA. The 0–4 h FEUA increased by 180%, at a dose of 30 mg/kg compared to the control (p < 0.01)[3].    

Advantages

Dotinurad, as a selective urate reabsorption inhibitor, is anticipated to be more effective in inhibiting urate reabsorption compared to conventional urate-lowering agents. It demonstrates noninferiority to benzbromarone or febuxostat in reducing serum urate levels in hyperuricemic patients with or without gout. Moreover, its effectiveness remains uncompromised in patients with mild to moderate renal or hepatic impairment. In a long-term study, a majority of patients achieved the target serum urate level of ≤6 mg/dL when administered a maintenance dose of 2 or 4 mg once daily. No safety concerns, such as liver injury, were observed. Consequently, Dotinurad is expected to serve as a new therapeutic option for hyperuricemic patients, regardless of the presence of gout [2].

References

[1] Tanaka A, et al. Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA). European Journal of Medical Research, 2023; 238.
[2] Ishikawa T, et al. Dotinurad: a novel selective urate reabsorption inhibitor for the treatment of hyperuricemia and gout. Expert Opinion on Pharmacotherapy, 2021; 22: 1397-1406.
[3] Taniguchi T, et al. Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor. Journal of Pharmacology and Experimental Therapeutics, 2019; 162-170.

Dotinurad Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Dotinurad Suppliers

NANJING TOMMLAB PHARMATECH Co.,LTD
Tel
--
Fax
--
Email
litianang@caremo.com.cn
Country
China
ProdList
271
Advantage
58
Wuhan HSN Pharmaresearch CO., LTD.
Tel
027-63499089 18086100502
Fax
027-86589137
Email
linwell@126.com
Country
China
ProdList
211
Advantage
50
Jinan Guoding Pharmaceutical Technology Co., Ltd.
Tel
15665775653
Fax
053167801621
Email
sales@guodingpharma.com
Country
China
ProdList
502
Advantage
58
Shanghai Wishpharma Co.,Ltd.
Tel
021-56789108 18694901298
Fax
021-56789108
Email
95413064@qq.com
Country
China
ProdList
266
Advantage
56
Huadong Microbiology Co., Ltd.
Tel
15858880160
Email
dingya@eastchinapharm.com
Country
China
ProdList
54
Advantage
58
Hubei widely chemical technology Co., Ltd.
Tel
027-59402396 13419635609
Fax
027-83989310
Email
13419635609@163.com
Country
China
ProdList
1985
Advantage
55
NANJING WEDO PHARMATECH CO.,LTD.
Tel
15189836218
Email
wedo-chem@huawe.com
Country
China
ProdList
159
Advantage
58
Bayee Biotech (Anqing) Co., Ltd.
Tel
0556-5032306 18917961636
Fax
+86-556-5032307
Email
wtx@bayeebio.com
Country
China
ProdList
261
Advantage
61
Jia Xing Isenchem Co.,Ltd
Tel
0573-85285100 18627885956
Fax
0573-85285100
Email
isenchem@163.com
Country
China
ProdList
9513
Advantage
66
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Fax
+86-25-83453306
Email
info@chemlin.com.cn
Country
China
ProdList
19179
Advantage
64
S.Z. PhyStandard Bio-Tech. Co., Ltd.
Tel
0755-4000505016 13380397412
Fax
0755 28094224
Email
3001272453@qq.com
Country
China
ProdList
5047
Advantage
50
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810
Fax
025-57019371
Email
sales@sunlidabio.com
Country
China
ProdList
3239
Advantage
55
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Fax
0755-28363542
Email
sales@chem-strong.com
Country
China
ProdList
18070
Advantage
56
Shanghai eliv pharmaceutical Co.,Ltd.
Tel
021-50158063
Fax
021-6153 1846
Email
sales@elivpharma.com
Country
China
ProdList
646
Advantage
58
Hangzhou Copiore Chemical Co., Ltd.
Tel
0571-56076030 13757145729
Fax
0571-56076030
Email
sales@copiore.com
Country
China
ProdList
272
Advantage
58
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9806
Advantage
58
ChengDu TongChuangYuan Pharmaceutical Co.Ltd
Tel
028-83379370 13880556291
Fax
028-87747383
Email
tcy@tcypharm.com
Country
China
ProdList
6271
Advantage
58
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Fax
21-5161 9052
Email
Sales@ATKchemical.com
Country
China
ProdList
7295
Advantage
58
Shanghai SuperLan Chemcial Technique Centre
Tel
021-2022843681 15618226720
Fax
+86-21-51601218
Email
lucy@atkchemical.com
Country
China
ProdList
9952
Advantage
58
Wuhan Wsem Biological Co., Ltd.
Tel
027-83778876 13667159345
Fax
027-83778876
Email
13667159345@163.com
Country
China
ProdList
1999
Advantage
55
Nanjing FuRuisi Medical Technology Co., Ltd.
Tel
025-83221260
Fax
02583221260
Email
renqing401@163.com
Country
China
ProdList
228
Advantage
55
Wellman Pharmaceutical Group Limited
Tel
027-83778875 15807197853
Fax
027-83991220
Email
15807197853@163.com
Country
China
ProdList
4028
Advantage
58
Beijing Mesochem Technology Co., Ltd.
Tel
010-57862036 18811083386
Email
msales@mesochem.com
Country
China
ProdList
205
Advantage
58
Changzhou Yongfeng Biomedicine Co. Ltd.
Tel
15006117673
Fax
2973592490@.com
Email
2973592490@qq.com
Country
China
ProdList
298
Advantage
58
Shenzhen Polymeri Biochemical Technology Co., Ltd.
Tel
+86-400-002-6226 +86-13028896684;
Email
sales@rrkchem.com
Country
China
ProdList
57423
Advantage
58
Nextpeptide Inc
Tel
+86-0571-81612335 +8613336028439
Email
sales@nextpeptide.com
Country
China
ProdList
19908
Advantage
58
DC Chemicals
Tel
021-58447131 13564518121
Email
sales@dcchemicals.com
Country
China
ProdList
9409
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11218
Advantage
58
wuhan dingxingtong Chemical Technology Co., Ltd Co., Ltd
Tel
027-59207796 13429867250
Fax
027-59207796
Email
w13429867250@163.com
Country
China
ProdList
1990
Advantage
58
Guangzhou Younan Technology Co., Ltd
Tel
020-82000279 18988968278
Fax
QQ:3283937693
Email
sales@ubiochem.com
Country
China
ProdList
4297
Advantage
58
Shanghai hongqu biomedical technology co. LTD
Tel
88888888888
Email
hongquchem@qq.com
Country
China
ProdList
5132
Advantage
58
Nanjing shengyilai Chemical Co., Ltd
Tel
19951936396
Email
3158688292@qq.com
Country
China
ProdList
4856
Advantage
58
Shanghai Yatan Pharmaceutical Research and Development Co. LTD
Tel
021-58003085 15865876430
Fax
QQ1060196522
Email
hujy@neutanpharma.com
Country
China
ProdList
173
Advantage
58
Wuhan Hongde Yuexin Pharmaceutical Technology Co., Ltd
Tel
02783850058 15377551550
Fax
027-83850058
Email
whhdyxchem027@sina.com
Country
China
ProdList
3269
Advantage
58
Zhejiang Huida Biotech Co., LTD
Tel
0571-89903882 13626641628
Email
jiangnan@huidabiotech.com
Country
China
ProdList
3656
Advantage
58
Hubei Zhongshan Medical Technology Co., Ltd
Tel
027-61907345 13397111514
Fax
3443707954
Email
w13397111514@163.com
Country
China
ProdList
1011
Advantage
58
Guangdong Xianqiang Pharmaceutical Co., Ltd.
Tel
020-87815159 13509815581
Email
tanshuhua@xianqiang.com
Country
China
ProdList
8
Advantage
58
Shanghai Sunway Pharmaceutical Technology Co.,Ltd.
Tel
021-51816796-820 13611835272
Fax
021-5161 3951
Email
sales2@sunwaypharm.com
Country
China
ProdList
44458
Advantage
58
Hangzhou Taorui Biotechnology Co., Ltd
Tel
4000-360-990 15268198094
Email
sales@torreybio.com
Country
China
ProdList
2889
Advantage
58
Changzhou Xianglong Pharmaceutical Technology Co., LTD
Tel
18661161657
Email
yaoxiangqiu2021@163.com
Country
China
ProdList
9996
Advantage
58
Jiangxi ravel Biotechnology Co.,Ltd
Tel
400-880-2824; 13184580281
Fax
400-880-2824
Email
hj@ruiweier.cn
Country
China
ProdList
2737
Advantage
58
Wuhan Wenjin Chemical Technology Co., Ltd.
Tel
13517196568
Email
375665891@qq.com
Country
China
ProdList
470
Advantage
58
QUALITY CONTROL SOLUTIONS LTD.
Tel
0755-66853366; 13670046396
Email
ORDERS@QCSRM.COM
Country
China
ProdList
24342
Advantage
58
Hubei wei shi reagent group ltd., company
Tel
027-59102966 18717199209
Fax
027-59379337
Email
2853877583@qq.com
Country
China
ProdList
2984
Advantage
58
Hubei Chenxin Pharmaceutical Co., Ltd.
Tel
18696113233
Fax
QQ:2544920688
Email
like1076463918@163.com
Country
China
ProdList
3160
Advantage
58
Zhejiang Huida Biotech Co., LTD
Tel
0571-0571-89903882 15990081639
Email
sunshixuan@huidabiotech.com
Country
China
ProdList
3705
Advantage
58
Molcoo Chemicals Inc.
Tel
18576690171 17386083646
Email
3001006472@qq.com
Country
China
ProdList
11837
Advantage
58
Bide Pharmatech Ltd.
Tel
400-1647117 13681763483
Email
product02@bidepharm.com
Country
China
ProdList
62075
Advantage
58
InvivoChem
Tel
13549236410
Email
sales@invivochem.cn
Country
China
ProdList
6753
Advantage
58
Jiangxi ravel Biotechnology Co.,Ltd
Tel
400-880-2824 15608648206
Email
1987516016@qq.com
Country
China
ProdList
2816
Advantage
58
More
Less

View Lastest Price from Dotinurad manufacturers

BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
Product
Dotinurad 1285572-51-1
Price
US $0.00/g
Min. Order
1g
Purity
More Than 99%
Supply Ability
50kg/Month
Release date
2024-07-03

1285572-51-1, DotinuradRelated Search:


  • Dotinurad
  • Methanone, (3,5-dichloro-4-hydroxyphenyl)(1,1-dioxido-3(2H)-benzothiazolyl)-
  • Dotinurad (FYU-981)
  • (3,5-dichloro-4-hydroxyphenyl)(1,1-dioxidobenzo[d]thiazol-3(2H)-yl)methanone
  • uricosuric,Inhibitor,Dotinurad,URAT1,urate,reabsorption,SLC22A12,Urate transporter 1,inhibit,transporter
  • (3,5-Dichloro-4-hydroxyphenyl)(1,1-dioxido-3(2H)-benzothiazolyl)methanone
  • 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole
  • 1285572-51-1
  • API